Julia Deparis1, Véronique Bonniaud2, David Desseauve1, Joëlle Guilhot3, Margot Masanovic4, Renaud de Tayrac5, Arnaud Fauconnier6,7, Xavier Fritel1,3. 1. Université de Poitiers, Faculté de Médecine et Pharmacie, CHU de Poitiers, Poitiers, France. 2. Réseau de Pelvi-Périnéologie, Rééducation, Centre Hospitalier Universitaire de Dijon, Dijon, France. 3. INSERM CIC 1402, CHU de Poitiers, Poitiers, France. 4. Centre Hospitalier Universitaire de La Réunion, Saint-Denis, France. 5. Centre Hospitalier Universitaire de Nîmes, Nîmes, France. 6. Centre Hospitalier Intercommunal de Poissy-Saint-Germain-en-Laye, Poissy, France. 7. Research unit EA 7285 (RISCQ), Université Versailles St-Quentin, Montigny-le-Bretonneux, France.
Abstract
AIMS: The Female pelvic floor questionnaire (FPFQ) is a self-administered tool on pelvic floor function. Our aim was to carry out a cultural adaptation of the FPFQ into French and to assess its psychometric properties. METHODS: After cross-cultural adaptation into French, acceptability and reliability of the questionnaire were assessed through a sample of 56 women in a test-retest. Discriminative construct validity was evaluated by comparing the results obtained by the FPFQ to those of other validated questionnaires. Longitudinal follow-up of the 282 pregnant women included in the PreNatal Pelvic floor Prevention trial (3PN) was used to analyze responsiveness. RESULTS: The proportion of missing data did not exceed 4% for questions about bladder function, bowel function, and pelvic organ prolapse; 10% for issues related to sexual function. Question 9 was considered difficult to understand by 14% of women. After rewriting, this issue was retested in a new sample of 52 women and presented no further problems. The intra-class correlation coefficient was greater than or equal to 0.7 for all domains during the test-retest. The FPFQ was strongly and significantly correlated (Spearman r > 0.5) with the other validated questionnaires. The French version of FPFQ recorded changes in urinary and sexual symptoms for the women involved in 3PN trial with a standardized response mean equal to 0.83 and 0.44, respectively. CONCLUSION: The French version of the FPFQ is self-administered, reliable, valid, and can detect a change in symptoms during follow-up. Neurourol. Urodynam. 36:253-258, 2017.
AIMS: The Female pelvic floor questionnaire (FPFQ) is a self-administered tool on pelvic floor function. Our aim was to carry out a cultural adaptation of the FPFQ into French and to assess its psychometric properties. METHODS: After cross-cultural adaptation into French, acceptability and reliability of the questionnaire were assessed through a sample of 56 women in a test-retest. Discriminative construct validity was evaluated by comparing the results obtained by the FPFQ to those of other validated questionnaires. Longitudinal follow-up of the 282 pregnant women included in the PreNatal Pelvic floor Prevention trial (3PN) was used to analyze responsiveness. RESULTS: The proportion of missing data did not exceed 4% for questions about bladder function, bowel function, and pelvic organ prolapse; 10% for issues related to sexual function. Question 9 was considered difficult to understand by 14% of women. After rewriting, this issue was retested in a new sample of 52 women and presented no further problems. The intra-class correlation coefficient was greater than or equal to 0.7 for all domains during the test-retest. The FPFQ was strongly and significantly correlated (Spearman r > 0.5) with the other validated questionnaires. The French version of FPFQ recorded changes in urinary and sexual symptoms for the women involved in 3PN trial with a standardized response mean equal to 0.83 and 0.44, respectively. CONCLUSION: The French version of the FPFQ is self-administered, reliable, valid, and can detect a change in symptoms during follow-up. Neurourol. Urodynam. 36:253-258, 2017.
Authors: Lea Tami Suzuki Zuchelo; Italla Maria Pinheiro Bezerra; Adna Thaysa Marcial Da Silva; Jéssica Menezes Gomes; José Maria Soares Júnior; Edmund Chada Baracat; Luiz Carlos de Abreu; Isabel Cristina Esposito Sorpreso Journal: Int J Womens Health Date: 2018-08-08
Authors: Monika Urbowicz; Mariola Saulicz; Aleksandra Saulicz; Edward Saulicz Journal: Int J Environ Res Public Health Date: 2022-02-13 Impact factor: 3.390